Targeting of Staphyloxanthin and α‐Hemolysin by Natural Compound L‐Malic Acid Suppresses Staphylococcus aureus Virulence
The FASEB Journal · 15.06.2026 · 40 (11)
DOI: 10.1096/fj.202600917r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 30.05.2026. Verfasst von Li Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Hemolysin Proteins, Staphylococcus aureus, Xanthophylls, Malates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
The escalating prevalence of antibiotic resistance in Staphylococcus aureus has underscored the urgent necessity for groundbreaking anti‐infective therapies that target novel pathways. Metabolic intermediates, such as those in the TCA cycle, have been known to be linked to bacterial virulence. L‐Malic acid (L‐MA), a natural TCA cycle intermediate, is known for its antimicrobial and antioxidant properties; however, its effect on the virulence of Staphylococcus aureus has yet to be explored. It was found that L‐malic acid not only inhibited bacterial growth but also markedly reduced the production of crucial virulence factors, including staphyloxanthin and α‐hemolysin. The suppression of pigment synthesis was primarily due to the competitive antagonism of CrtO, a key oxidoreductase responsible for carotenoid biosynthesis in Staphylococcus aureus , coupled with enhanced flux through the TCA cycle that redirected acetyl‐CoA pools away from the mevalonate pathway. Moreover, hemolytic activity was decreased by lowering the expression of α‐hemolysin. In vivo studies using mouse infection models further demonstrated that L‐malic acid effectively mitigated the pathogenicity of Staphylococcus aureus , significantly reducing the formation of skin and liver abscesses. These findings position L‐malic acid as a promising agent targeting Staphylococcus aureus infections, highlighting the need for further research into its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Li Shen
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Shen, L., Wang, B., Yang, J., Yuan, X., Chen, Z., Yang, C., Fu, J., Gao, H., Han, W., Shi, J., Yu, F., & Yu, J. (2026). Targeting of Staphyloxanthin and α‐Hemolysin by Natural Compound L‐Malic Acid Suppresses Staphylococcus aureus Virulence. The FASEB Journal, 40(11). https://doi.org/10.1096/fj.202600917r
Vancouver
Shen L, Wang B, Yang J, Yuan X, Chen Z, Yang C, et al. Targeting of Staphyloxanthin and α‐Hemolysin by Natural Compound L‐Malic Acid Suppresses Staphylococcus aureus Virulence. The FASEB Journal. 2026;40(11). doi:10.1096/fj.202600917r
BibTeX
@article{Shen2026,
author = {Shen, Li and Wang, Bingjie and Yang, Jinjin and Yuan, Xinru and Chen, Zhixuan and Yang, Can and Fu, Jiana and Gao, Haojin and Han, Weihua and Shi, Junhong and Yu, Fangyou and Yu, Jingyi},
title = {Targeting of Staphyloxanthin and α‐Hemolysin by Natural Compound L‐Malic Acid Suppresses Staphylococcus aureus Virulence},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {11},
doi = {10.1096/fj.202600917r}
}
EUVIMED